Abstract
Survival of antigen-specific CD8+ T cells in peripheral lymphoid organs during viral infection is known to be dependent predominantly on IL-7 and IL-15. However, little is known about a possible influence of tissue environmental factors on this process. To address this question we studied survival of memory antigen-specific CD8+ T cells in the small intestine. Here, we show that 2 months after vaccinia virus infection, B8R20–27/H2-Kb tetramer+ CD8+ T cells in the small intestinal intraepithelial (SI-IEL) layer are found in mice deficient in IL-15 expression. Moreover, SI-IEL and lamina propria lymphocytes do not express the receptor for IL-7 (IL-7Rα/CD127). In addition, after in vitro stimulation with B8R20–27 peptide, SI-IEL cells do not produce high amounts of IFN-γ either at 5 days (5d) or at 2 months post infection (p.i.). Importantly, the lack of IL-15 was found to shape the functional activity of antigen-specific CD8+ T cells, by narrowing the CTL avidity repertoire. Taken together, these results reveal that survival factors as well as functional activity of antigen-specific CD8+ T cells in the SI-IEL compartments may markedly differ from their counterparts in peripheral lymphoid tissues.
1. Introduction.
Gastrointestinal mucosa represents a major site of entry as well as initial replication for many viral and bacterial pathogens (including HIV). Massive depletion of CD4+CCR5+ memory T cells occurs in the mucosal tissues within the first two weeks of HIV-1 infection [1, 2]. In connection with this, vaccines providing protection against gastrointestinal infectious diseases must be able to induce long-term mucosal immune responses [3–9]. Previously, we demonstrated that long-lasting protection against mucosal viral transmission could be accomplished by CD8+ CTLs that must be present at the mucosal site of antigen exposure, although some mucosal memory CTLs maybe induced even after systemic vaccination [10–16]. This protective effect was ablated when CD8+ cells were depleted in vivo, and required that CTL were present in the gut mucosa, whereas splenic CTLs alone were unable to protect against mucosal viral challenge [10]. Thus, unless antibodies are able to completely prevent viral entry, induction of local long-lasting mucosal CD8+ CTLs in the gut should be considered essential to design a protective mucosal vaccine.
The maintenance of antigen-specific CD8+ T cells, their homeostatic proliferation and survival during the memory phase of immune responses are known to be predominantly dependent on IL-15 and IL-7, respectively [17–26]. Other cytokines elicited by infectious (or tumor) antigens may work during the primary response as endogenous adjuvants, and could contribute to the survival of long-lived memory CD8+ T cells [27–30]. Based on proliferative potential, cytokine production, and surface phenotype, memory CD8+ T cells can be divided into effector (EM) and central (CM) memory cells [31, 32]. One approach to discriminate between these two subsets is based on detection of surface IL-7Rα/CD127 and CD62L, where EM have CD127+CD62L– phenotype whereas CM should be CD127+CD62L+. In peripheral lymphoid tissues both CD8+ T cell memory subsets may be found, but in the case of non-lymphoid tissues, EM CD8+ T cells are expected to be more prevalent due to the differences in migratory pathways used [33]. Mechanisms of CD8+ CTL survival in mucosal tissues, in particular, in the small intestinal IEL (SI-IEL) and lamina propria (SI-LP) are not well understood yet [33–35]. Here, we addressed a role that IL-15 and IL-7 play for survival of memory intraepithelial CD8+ T cells in the small intestine in mice that were mucosally vaccinated with Modified Vaccinia Ankara (MVA). We found that 2 months after MVA was intrarectally (IR) administered, virus-specific B8R20–27/H2-Kb tetramer (B8R tetramer)+ CD8+ T cells were present in the SI-IEL. Surprisingly, these cells in WT mice were mainly CD127–CD62L–, in sharp contrast to the B8R tetramer+ CD8+ T cells found in the spleens of the same animals (EM and CM). Additionally, B8R20–27-specific CTLs isolated from the SI-LP were CD127–CD62L– as well. Moreover, such long-living CD127– CD8+ T cells were found in the SI-IEL isolated from IL-15 KO mice, indicating that some CD8+ T cell subpopulation is able to survive within the gut epithelial layer in the absence of both IL-7 and IL-15 signaling. To find out which surface markers could be associated with residual survival of memory CD8+ CTLs in the gut, cells from WT and IL-15 KO mice were analyzed by flow cytometry for surface expression of CD11a, CD11c, NKG2D, and CD8αα homodimer. We found that none of these markers was expressed by the majority of the gut memory CD8+ CTLs.
Thus, we may conclude that the antigen-specific memory CD8+ CTLs residing in the SI-IEL compartment may be maintained for a long-term independently of signaling via IL-7 and IL-15. Their survival may be dependent on soluble and/or cell contact signals which substitute for cytokines specific predominantly for lymphoid tissues. Identifying these tissue-specific pro-survival mechanisms may be crucial for development of new strategies for mucosal vaccination.
2. Results
2.1. Absence of IL-15 affects antigen-specific CD8+ T cell response in mucosally vaccinated mice
In order to estimate quantitative and qualitative effect of IL-15 of antigen-specific CD8+ T cell response WT and IL-15 KO mice were IR inoculated with MVA. As a readout we assessed MVA-specific CTL expansion and contraction as well as their functional activity during acute (d5) and memory (2 months) phases postinfection, respectively. To enhance sensitivity of our model, especially in IL-15 KO animals, we measured immune response against the immunodominant vaccinia virus B8R20–27 epitope [36]. By flow cytometry, in WT mice during the acute phase (5d) of infection, a robust immune response was found, with high relative percentages of B8R tetramer+ CD8+ T cells in the spleen as well as in SI-IEL (Fig.1, Table 1). By d13 their frequencies both in SI-IEL and spleen decreased approximately two-fold compared with their level at d5, and contracted to as low as 1–2% by 2 months after immunization. In sharp contrast, in IL-15 KO mice, the presence of B8R tetramer+ CD8+ T cells was substantially lower compared with WT mice, throughout the experiment (compare WT vs. IL-15 KO: spleen, 5d – 20.62±1.12 vs. 9.97±2.03, p=0.0101; 13d – 10.70±0.78 vs. 1.47±0.15, p=0.0003; 2 months – 1.73±0.12 vs. 1.53±0.09, p>0.05; SI-IEL, 5d – 23.83±1.58 vs. 3.34±0.29, p=0.0002; 13d – 13.39±0.68 vs. 3.20±0.75, p=0.0006; 2 months – 1.59±0.17 vs. 1.19±0.36, p>0.05). Difference in kinetics between WT and IL-15 KO mice was more evident when we estimated absolute numbers of B8R tetramer+ CD8+ T cells in the spleen and the SI-IEL (Fig.1; compare WT vs. IL-15 KO: spleen, 5d – 1.49±0.09 (x106) vs. 0.15±0.03 (x106), p=0.0002; 13d – 0.64±0.03 (x106) vs. 0.11±0.03 (x106), p=0.0003; 2 months – 0.09±0.01(x106) vs. 0.03±0.01(x106), p=0.0017; SI-IEL, 5d – 1.76±0.07(x106) vs. 0.08±0.02 (x106), p<0.0001; 13d – 0.77±0.04 (x106) vs. 0.15±0.01(x106), p<0.0001; 2 months – 0.43±0.02 (x106) vs. 0.05±0.01(x106), p=0.0001).
Fig.1. Kinetics of B8R20–27/H2-Kb tetramer+ CD8+ T cells in the spleen and SI-IEL of C57BL/6 and IL-15 KO mice.

Relative percentages (upper panel) and absolute numbers (lower panel) of B8R tetramer+ CD8+ T cells recovered from the spleen and SI-IEL of WT and IL-15 KO mice are presented. Lymphocytes were isolated 5d, 13d, and 2 months after IR immunization with MVA 107 pfu/mouse. Cells were stained with PE-conjugated B8R20–27/H2-Kb tetramer together with anti-CD8α (spleen) or anti-CD8β (SI-IEL) mAbs. Data shown are the mean+SD of three animals per group. Experiments were performed twice with comparable results. Data were analyzed by unpaired Student’s t-test. * p<0.05, **p<0.01, *** p<0.0001, ns: not significant.
Table 1.
Phenotype of memory B8R20–27-specific CD8+ T cells in the SI-IEL and spleen from WT and IL-15 KO mice.
| Tissue | Marker | Time after infection | |||
|---|---|---|---|---|---|
| 5 days | 2 months | ||||
| WT | IL-15 KO | WT | IL-15 KO | ||
| SI-IEL | CD127+CD62L– CD127+CD62L+ |
1.62±0.16 |
2.23±0.38 |
ND | ND |
| ND | 1.17±0.46 | ND | 2.93±1.13 | ||
| CD11c+CD11a– CD11c+CD11a+ CD11c–CD11a+ |
1.11±0.48 7.90±0.49 71.00±3.51 |
11.27±0.71# 17.50±1.04## 37.63±1.45* |
17.90±1.99 3.33±0.52 ND |
12.70±1.46 3.12±0.19 ND |
|
| NKG2D+ | 1.40±0.12 | 8.40±0.70** | 11.37±0.45 | 10.40±2.45 | |
| SI-LP | CD127+CD62L– | 0.07±0.07 | 0.07±0.03 | ND | NEC |
| CD127+CD62L+ | ND | ND | ND | NEC | |
| CD11c+CD11a– | 0.47±0.15 | NEC | 14.70±0.85 | NEC | |
| CD11c+CD11a+ | 24.60±1.70 | NEC | ND | NEC | |
| CD11c–CD11a+ | 61.00±2.08 | NEC | ND | NEC | |
| NKG2D+ | 0.32±0.08 | 21.00±1.91 | 20.73±1.69 | NEC | |
| Spleen | CD127+CD62L– | 1.73±0.07 | 1.53±0.05 | 73.33±3.28 | 66.90±3.77 |
| CD127+CD62L+ | 2.20±0.30 | 1.63±0.08 | 15.00±2.52 | 19.67±1.45 | |
| CD11c+CD11a– | 6.58±0.36 | 2.56±0.59 | 1.03±0.09 | 0.23±0.15 | |
| CD11c+CD11a+ | 71.77±3.26 | 67.40±2.91 | 42.33±2.03 | 43.23±1.75 | |
| CD11c–CD11a+ | 15.73±0.94 | 16.07±0.55 | 40.53±1.81 | 42.77±1.97 | |
| NKG2D+ | 70.97±2.00 | 61.13±3.21 | 80.30±1.31 | 72.43±3.35 | |
Comments: Lymphocytes from WT and IL-15 KO animals were isolated at 5d and 2 months after IR immunization with MVA 107 pfu/mouse. Four-color flow cytometry was performed. Cells from tissues were stained with PE-conjugated B8R20–27/H2-Kb tetramer together with CD8α mAbs. Then, cells were gated on tetramer+ CD8+ T cells, and further analyzed for expression of CD127, CD62L, CD11a, CD11c, and NKG2D markers expression. Data shown are the mean percent of gated cells and SEM of three animals per interval and are one representative experiment of two experiments performed with comparable results.
Abbreviations: ND – not detected; NEC – not enough cells: due to the paucity of the total isolated LP cells as well as recovered B8R20–27/H2-Kb tetramer+ CTLs;
– p=0.00057;
– p=0.00434;
– p=0.00487;
– p=0.00623.
It is well-known that IL-15 is a crucial cytokine necessary not only for survival of memory CD8+ T cells, but also for their functional activity. To ascertain functional avidity, we quantitated IFN-γ production by splenocytes and SI-IEL (by ELISpot assay). We found that splenocytes from WT animals (Fig. 2A, upper panel; Fig.2B and C show normalized and net IFN-γ response as percentaage of max. and total response, respectively) showed IFN-γ production in response to titrated amounts of B8R20–27 peptide. This response was at peak during acute phase (5d) after immunization, and declined with time. In contrast, in IL-15 KO mice the magnitude of response to the highest dosage of B8R20–27 peptide (1μM; characterizes total responders to peptide epitope), was significantly lower (compare WT vs. IL-15 KO: 5d. – 1358.67±311.10 vs. 430.00±164.62, p=0.0577). Furthermore, the immune response in IL-15 KO mice decreased with time more abruptly, as it was already markedly diminished at 13d after vaccination (WT vs. IL-15 KO: 506.67±116.09 vs. 35.33±5.24, p=0.0072). Importantly, in IL-15 KO mice we detected almost complete lack of CD8+ T cells having high functional avidity (recognizing 1pM of B8R20–27 peptide), which was already evident during the acute phase (compare WT vs. IL-15 KO: 5d – 110.33±6.06 vs. 43.33±5.81, p=0.0624; 13d – 61.33±3.53 vs. 21.00±2.65, p=0.0059; 2 months – 41.00±2.31 vs. 10.00±0.58, p=0.0002). Thus, IL-15 was found to be important not only for maintenance of antigen-specific CD8+ T cells during the memory phase (2 months postinfection), but also for generation of cells with full functional capacity (high functional avidity).
Fig.2. Functional avidity of B8R-specific CD8+ T cells for IFN-γ production in the spleen and SI-IEL of C57BL/6 and IL-15 KO mice.

(A-C) Splenic (upper panels) and SI-IEL (lower panels) populations were isolated from WT and IL-15 KO animals 5d, 13d, and 2 months after infection, and treated with B8R20–27 peptide to perform ELISpot for IFN-γ production. B8R20–27 peptide (1μM, 100pM, 1pM) was added directly to the tissue leukocyte populations, which were placed in triplicates (see Materials and Methods). (A) Absolute numbers of responders/106 total leucocytes to different peptide concentrations are shown. (B) Normalized data calculated against the response to 1μM of peptide are shown. Dotted line corresponds to 50%max.response (max.response=1μM peptide concentration). (C) Percentage of responders out of total response are shown [53]. Data are the mean+SD of three animals per group. Experiments were performed twice with comparable results.
In contrast to what was found in the spleen, IFN-γ production in the SI-IEL compartment from the WT animals was barely detectable 2 months after immunization (Fig.2, lower panel; compare 5d vs. 2 months 1μM: 666.67±370.33 vs. 18.33±3.18). Also, this response was characterized by skewing to the presence of cells recognizing high and middle concentrations of B8R20–27 peptide (1μM and 100pM) that further distinguishes them from the splenic counterparts (compare spleen vs. SI-IEL, 5d: 1μM – 1358.67±311.10 vs. 666.67±370.33; 100pM – 506.67±116.09 vs. 421.33±239.88; 1pM – 41.00±4.00 vs. 0.90±0.17). Strikingly, although B8R tetramer+ CD8+ T cells can be detected in SI-IEL in IL-15 KO animals, these cells had almost completely lost capacity to produce IFN-γ even at the peak of infection (Fig.2; compare 5d vs. 13d: 1μM – 7.90±4.55 vs. 6.53±3.31, p>0.05).
2.2. High physical avidity and TCR expression level may not correspond to functional avidity of CTLs from non-lymphoid tissues
Based on the ELISpot data, we reasoned that physical avidity of TCR B8R tetramer+ CD8+ T cells might affect their functional capacity. To check this possibility we assessed by flow cytometry the level of TCR expression on B8R tetramer+ CD8+ T cells (Fig.3: panel A shows staining of naïve splenoctes and SI-IEL, panel B shows the strategy for gating cells as exemplified on WT cells 5d p.i.). We found that two uneven populations with high and low TCR expression were present both in the spleen and SI-IELs (Fig.3C). Interestingly, during the acute and memory phases, B8R tetramer+ CD8+ T cells in the spleen from both WT and IL-15 KO animals had comparable percentage of cells with high TCR expression (WT vs. IL-15 KO: 72 and 65 and 70 and 66%, respectively). In contrast, a different pattern was found in the SI-IEL. Whereas at the acute phase CTLs in both mouse strains highly expressed TCR at comparable, but still lower frequency compared to the spleen (WT vs. IL-15 KO: 55 and 50%, respectively), however, during the memory phase the cells from WT but not IL-15 KO expressed the TCR at the same or even higher level (WT vs. IL-15 KO: 72 vs. 32%, respectively). In fact, among memory CTL in the SI-IEL of the IL-15 KO animals, the majority of B8R tetramer+ CD8+ T cells expressed TCR at low levels (compare d5 vs. 2 months: 49 vs. 67%, respectively). Thus, MVA-specific SI-IEL from the IL-15 KO mice but not from WT animals had selective tissue-specific decline in frequency of B8R tetramer+ cells that expressed TCR at high level, that was progressing from the acute to the memory phase. The extensive and sustained TCR downregulation in the absence of IL-15 may be linked to a higher activation status of these cells and may be associated with a lower production of IFN-γ in IL-15KO animals. Additionally, by using B8R20–27/H-2Kb tetramer, we measured mean fluorescence intensity of vaccinia virus-specific CTLs stained with different concentrations of tetramer, which reflects the relative physical TCR avidity [37, 38]. For this we isolated tissues from the WT animals 5 days after IR infection with MVA. Comparison of the curves for CD8+ T cells from the SI-IEL versus spleen (Fig.4, left panel) revealed that the MVA-specific CTLs expressed TCR with rather high physical avidity for B8R20–27. Interestingly, the LP cells, which are anatomically adjacent to the IEL, had slightly lower TCR avidity, but still it was much higher compared with the spleen. Similar results were obtained when we depicted the same data as a % of max. MFI level, determining an average tetramer dilution factor giving 50% max.MFI (Fig.4, right panel): spleen – 1:60, SI-LP – 1:80, SI-IEL – 1:200.
Fig.3. TCR expression level on B8R-specific CTLs from SI-IEL and spleen isolated during acute and memory phase after IR MVA-immunization.

Cells from WT and IL-15 KO mice were isolated during acute and memory phases as indicated in the Materials and Methods, and stained with PE-conjugated B8R20–27/H2-Kb tetramer. Both splenic and SI-IEL cells were co-stained with anti-CD8α and CD8β (spleen) mAbs. Then, B8R tetramer+ CD8β+-gated CTLs were plotted against CD8α. The level of B8R tetramer staining is shown. (A) The control staining of lymphocytes from naïve animals was performed and a very low background was detected. (B) Originally, cells were gated on B8R tetramer+ CD8β+ T cells as exemplified on WT cells, day 5 post infection. (C) TCR level expression on B8R tetramer+ CTLs from spleen and SI-IEL is shown on density plots and presented as percentage out of total B8R tetramer+ CTLs. Data from a representative staining are shown. Comparable results were found in 3 mice studied.
Fig.4. Small intestinal B8R-specific IEL have high physical avidity for vaccinia virus B8R20–27 epitope.

Cells from spleen (circles), SI-IEL (quadrants) and SI-LP (triangles) were isolated from WT mice 5 days after IR immunization with 107 pfu MVA, and stained with anti-CD8β Abs and B8R tetramer at the indicated dilutions. Left, Mean fluorescence intensities (MFI) of CD8β+ T cells representative of 3 mice per tissue from two comparable experiments are shown. Right, Normalized MFI of CD8β+ T cells presented as a percentage out of max.MFI level.
Altogether, we may conclude that data on functional and physical avidity of MVA-specific CTLs isolated from spleen (lymphoid tissue) correspond to each other, whereas in the SI-IEL and SI-LP (non-lymphoid tissues) they do not. It may imply that not only cell-intrinsic features (physical avidity) may shape CTL functional activity, but cell-extrinsic parameters as well, especially in case of non-lymphoid tissues (cytokine milieu, co-stimulatory molecules). Our data on MFI of tetramer+ cells in IEL and LP compared to spleen in the memory phase cannot answer this question.
2.3. Memory Antigen-specific CD8+ T cells in SI-IEL and SI-LP from IL-15 KO mice lack IL-7Rα/CD127 expression
It is known that both IL-7 and IL-15 are of crucial importance for homeostatic proliferation of memory CD8+ T cells [17, 24, 39]. In particular, IL-15 signals are considered to be more important for homeostatic proliferation of memory CD8+ T cells, whereas IL-7 signals are responsible for their survival [31]. However, what defines pro-survival conditions for memory CD8+ T cells in different non-lymphoid tissues, including the gut, is not well understood. At least for the cells from the SI-LP it was shown that they may survive due to signals provided by non-hematopoietic cells via CD70 [40]. As was recently demonstrated by Jiang w. et al., [41] the residual c-Myc-deficient CD8 αα TCR αβ IEL display reduced proliferation and increased apoptosis, which correlate with significantly decreased expression of interleukin-15 receptor subunits and lower levels of the antiapoptotic protein Bcl-2 [41]. Thus, c-Myc controls the development of CD8αα TCR αβ IELs from thymic precursors apparently by regulating IL-15 receptor expression and consequently Bcl-2-dependent survival [41]. It is well accepted that IEL are slower proliferating cells compare to other lymphoid cells. In many experimental systems, IEL alone did not show activation-induced proliferation, but they significantly inhibited the proliferation of activated lymph node T cells in a cell number-dependent manner [42].
To determine whether the cells from the SI-IEL comply to the same pro-survival strategy, we first assessed by flow cytometry whether the B8R tetramer+ CD8+ T cells express CD127 (IL-7Rα). Memory CD8+ T cells in the spleens in both mouse strains developed towards EM (CD127+CD62L–) and CM (CD127+CD62L+) subsets at comparable frequencies (Fig.5; Table 1). Surprisingly, however, very few memory B8R tetramer+ CD8+ SI-IEL both in WT and IL-15 KO mice (Fig.5; Table 1) expressed CD127. The same was true for the gut cells analyzed during the acute phase as well. In addition, SI-LPL from WT mice were also negative for CD127 expression during the entire experiment, and in IL-15 KO animals it was proved at least at the acute phase (Fig.5; Table 1). Thus, memory B8R-specific CD127lo/–CD8+ T cells residing in the SI-IEL compartment can be found not only in WT mice but also in the IL-15 KO.To evaluate whether residual IL-7Rα/CD127+ lymphocytes in the SI-IEL were still able to transduce signals from IL-7, we isolated SI-IELs, and treated them in vitro with recombinant murine IL-7 cytokine (rmIL-7; 200 ng/mL, 20 min at 37°C), followed by subsequent staining for intracellular phosphorylated STAT5 protein. As CTLs from naïve and antigen-experienced mice contain comparable low frequency of CD127+ cells (our unpublished data) and due to the paucity of antigen-specific CD8+ CTLs recoverable from SI-IEL compartment especially at the memory stage, we used SI-IEL from naïve mice. As a control we used splenocytes. As shown in Fig.6A and B, a much smaller proportion of total SI-IELs was able to mediate IL-7-dependent STAT5 phosphorylation compared with total splenocytes (solid black and grey lines, respectively). The relative percentage of IL-7Rα/CD127+ cells almost completely corresponded to the frequency of IL-7-treated STAT5 (Y694)+ cells both in the SI-IEL (5±0.8 and 4.5±0.3, respectively) and the spleen (16.0±0.7 and 20.1±1.3, respectively). Thus, these results confirm that the cells from the spleen as well as SI-IEL express functional receptor for IL-7, but the proportion of TCRαβ+CD8αβ+ SI-IEL that express functional IL-7Rα/CD127 is miniscule and much smaller than in the spleen (Fig. 6B).
Fig.5. Memory B8R tetramer+ CD8+ T cells in SI-IEL from WT and IL-15 KO mice express CD127 at low level.

Lymphocytes from WT and IL-15 KO animals were isolated at 5d and 2 months after IR immunization with MVA 107 pfu/mouse. Four-color flow cytometry was performed. Cells from IEL, LP and spleen were stained with PE-conjugated B8R tetramer together with anti-CD8α mAbs. Then, cells were gated on tetramer+ CD8+ T cells, and further analyzed for CD127 and CD62L marker expression. Due to the paucity of cells isolated from the lamina propria of IL-15 KO mice at 2 months p.i., these data are not presented. One out of two representative experiments is shown.
Fig.6. Residual CD127/IL-7Rα expression on naïve CD8+ T cells from WT SI-IEL induces IL-7-specific STAT5 phosphorylation.

Lymphocytes from naïve WT animals were isolated as described in Materials and Methods. Then cells were either treated with recombinant murine IL-7 in DPBS/1%BSA (rmIL-7; 200 ng/mL, 20 min at 37°C) or kept untreated. (A) Histograms for intracellular phospho-STAT5 (Y694) expression on total splenoctes and SI-IEL before and after adding rmIL-7 representative of 2 mice per tissue from two comparable experiments are shown. (B) Relative percentages of IL-7-induced intracellular STAT5 (Y694)+ total splenic and IEL populations from naïve WT mice. Isolated cells were treated in vitro with IL-7 (see Materials and Methods). Data show representative example from one of two experiments. Error bars indicate mean+SD. Data were analyzed by Mann-Whitney test, **** p< 0,0001.
2.4. Memory Antigen-specific CD8+ T cells in the SI-IEL from IL-15 KO mice barely express CD11a, CD11c NKG2D, and CD8αα homodimer
The prevalence during both acute and memory phases after immunization of MVA-specific CTLs lacking IL-7 receptor in the SI-IEL from both WT and even IL-15 KO animals suggested that during the memory phase, SI-IELs might survive by using alternative pathways without IL-7 or IL-15 signaling. Until recently several attempts have been taken to phenotype memory CD8+ T cells in SI-IEL in WT as well as TCR transgenic mice [34, 43]. Based on these reports, we decided to study expression of plausible candidates (β2-integrins CD11a and CD11c, and NKG2D) that could be associated with the gut specific survival of memory CTLs.
At 5d after immunization, B8R tetramer+ CD8+ T cells in the SI-IEL from WT and, to a lesser extent, in IL-15 KO animals, abundantly expressed CD11a integrin (Fig.7, upper panel; Table 1), and a few of them were CD11a+CD11c+ (7.90±0.49 vs. 17.50±1.04 for WT vs. IL-15 KO, p=0.00434; whereas the majority were CD11a+CD11c–: 71.00±3.51 vs. 37.63±1.45, p=0.00487). The same pattern was observed for the MVA-specific CTLs from the LP (Table 1 and data not shown). In sharp contrast, B8R tetramer+ CD8+ T cells from the spleen in both mouse strains revealed an inverse pattern of expression, where the CD11a+CD11c+ subset was dominant, and CD11a+ CD11c– was subdominant. It is interesting that 2 months after immunization, the majority of B8R tetramer+ CD8+ T cells in SI-IEL lost surface CD11a expression, and few of them were positive for CD11c both in WT and IL-15 KO mice (Fig.7; Table 1). In contrast, in the spleen the vast majority of these cells was expressing CD11a+ (>80%) being either single positive (CD11a+) or double-positive (CD11a+,CD11c+) (Table 1). Thus, although at early stages both CD11a and CD11c may be induced on the SI-IEL population, during the memory phase they were downregulated irrespective of the presence or absence of IL-15 in vivo, and thus these markers could not be associated with their survival.
Fig.7. Memory B8R tetramer+ CD8+ T cells in SI-IEL from WT and IL-15 KO mice express CD11a and CD11c at low level.

Lymphocytes from WT and IL-15 KO animals were isolated at 5d and 2 months after IR immunization with MVA 107 pfu/mouse. Four-color flow cytometry was performed. Cells from IEL, LP and spleen were stained with PE-conjugated B8R tetramer together with anti-CD8α mAbs. Then, cells were gated on tetramer+ CD8+ T cells, and further analyzed for CD11a and CD11c marker expression. Due to the paucity of isolated cells from the LPL of IL-15 KO mice at 5d and 2 months p.i. these data are not presented. One out of two representative experiments is shown.
Apart from the β2-integrins, the NKG2D molecule is also known to transduce co-stimulatory and/or pro-survival signals after binding to a number of its ligands expressed by the gut epithelial cells. At the acute stage few B8R tetramer+ CD8+ T cells in SI-IEL and SI-LP from the WT mice expressed NKG2D, whereas in IL-15 KO mice this frequency was modestly increased (Fig.8, upper panel; Table 1, compare WT vs. IL-15 KO: 1.40±0.21 vs. 8.40±0.70, p=0.00623). In contrast, in the spleen from both mouse strains, most antigen-specific CD8+ T cells were positive for NKG2D (Table 1), although in IL-15 KO mice their frequency was slightly lower. When the cells were checked during the memory phase, we saw that in all tissues (SI-IEL, spleen, and SI-LP,) from WT mice, especially in the gut, the relative percentage of NKG2D+ tetramer+ CD8+ T cells had increased compared to the acute phase (Fig.8, lower panel; Table 1) but was still much smaller than that found in the spleen. In contrast, in IL-15 KO animals, the percentage of NKG2D+ cells did not change with time.
Fig.8. Memory B8R tetramer+ CD8+ T cells in SI-IEL from WT and IL-15 KO mice express NKG2D at low level.

Lymphocytes from WT and IL-15 KO animals were isolated at 5d and 2 months after IR immunization with MVA 107 pfu/mouse. Triple-color flow cytometry was performed. Cells from IEL, LP and spleen were stained with PE-conjugated B8R tetramer together with anti-CD8β mAbs. Then, cells were gated on tetramer+ CD8+ T cells, and further analyzed for NKG2D marker expression. Due to the paucity of isolated cells from the LP of IL-15 KO mice at 2 months p.i. these data are not presented. One out of two representative experiments is shown.
Along with that, previously it was shown that some of the memory CTLs may express CD8αα homodimer, which may ligate an MHC-class I-like molecule, thymus leukemia (TL) antigen, known to be abundantly expressed on the basolateral membrane of mouse intestinal epithelium [44, 45]. When we checked appearance of CD8αα homodimer within the B8R tetramer+ CD8+ T cells from the SI-IEL, we found that whereas 5d after infection SI-IEL expressed CD8αα homodimer at comparable frequency in both mouse strains (Fig.9, upper panel), spleen cells did not express it at all. Interestingly, the frequency of CD8αα homodimer-positive cells in IL-15 KO mice was approx. 3-fold higher compared with WT animals. During the memory phase no changes in relative percentage of CD8αα+ cells were seen in either mouse strains when compared with d5, nor were positive cells found in the spleens.
Fig.9. Memory B8R tetramer+ CD8+ T cells in SI-IEL from IL-15 KO mice contain a higher frequency of CD8αα-homodimer+ cells than WT mice.

Splenocytes and SI-IEL from WT and IL-15 KO animals were isolated at 5d and 2 months after IR immunization with MVA 107 pfu/mouse. Triple-color flow cytometry was performed. Cells were stained with PE-conjugated B8R tetramer together with anti-CD8α and anti-CD8β mAbs. Then, cells were gated on tetramer+ CD8+ T cells, and further analyzed for expression of CD8αα-homodimer. One out of two representative experiments is shown.
Thus, memory B8R tetramer+ CD8+ T cells residing in the SI-IEL compartment in both WT and IL-15 KO animals modestly express CD127, CD11c and NKG2D, but not CD11a. The relative frequency of CD8αα homodimer-positive cells in the SI-IEL did not change with time, and has mouse-strain-specific features. In contrast, in both WT and IL-15 KO mice, the vast majority of memory B8R tetramer+ CD8+ T cells from the spleen expressed CD11a and NKG2D, and some of them were positive for CD11c.
CD103 may also be involved in the maintenance of memory cells at mucosal sites. However, a study by Masopust et al., concluded that memory CTL IEL are positive for CCR9, and less so for CD103 [46].
Altogether, the data obtained allow us to conclude that although memory CTLs can be found in the SI-IEL, which factors contribute to their survival in the absence of signaling via IL-7, IL-15, CD11a and/or CD11c integrins, NKG2D, and CD8αα homodimer remains unknown.
3. Discussion
Development of protective immunity is intrinsically connected to the route of infection [46–50]. However, generation and survival of antigen-specific CD8+ T cells after IR immunization is not well understood [10, 51, 52]. In this study we continued to characterize: 1) the kinetics of CD8+ T cell responses in the gut after IR immunization, 2) the dependency of functional activity and survival of antigen-specific CD8+ T cells from the SI-IEL compartment on IL-7 and IL-15 signals.
We found that the immune response in the spleen and SI-IEL compartment from WT mice was characterized by induction of B8R tetramer+ CD8+ T cells that paralleled each other during both expansion and contraction phases (Fig.1). Response against the immunodominant vaccinia virus B8R20–27 epitope (also present in the MVA), may elicit as high as 12% total splenic CTLs or up to 10 × 106 vaccinia-virus-specific CTLs [36]. These data perfectly fit to our results (Fig.1). However, we saw that the number of IFN-γ-producing cells (Fig.2) was much lower for the SI-IEL compartment despite the substantial presence of B8R tetramer+ CD8+ T cells. As was shown here and in our recent study [53] memory B8R20–27-specific CD8+ T cells in the SI-IEL compartment modestly produced IFN-γ, but with low avidity, whereas in the spleen they were characterized by populations with low-, middle-, and high functional avidity. In addition, B8R20–27-specific CD8+ T cells from the LP were previously shown to be uniquely enriched in the high avidity cells [53]. Thus, after mucosal immunization, CD8+ T cells with different functional avidity were distributed unequally in different mucosal and systemic sites. As shown in the current study even greater changes in functional activity were found in IL-15 KO mice, in which T cells tended to quickly loose their IFN-γ−producing capacity. Strikingly, in the SI-IEL compartment from IL-15 KO animals even at the peak of immune response a very modest response was detected (Fig.2, d5).
As functional avidity may be directly linked to the physical TCR avidity and high TCR expression level we compared them for B8R tetramer+ CTLs from SI-IEL vs. spleen. Interestingly, we found that the modest functional activity of B8R20–27-specific CD8+ T cells from the WT SI-IELs did not correspond tightly to the TCR expression level by the B8R tetramer+ CD8+ T cells (Fig.3, lower panels labeled with dates). In particular, whereas at the acute phase (d5) the SI-IEL from the WT mice had a pronounced in vitro IFN-γ production, however, only half of them were characterized by high TCR level expression. In contrast, during the memory phase, although they had hardly detectable functional activity, still the vast majority of them expressed TCRs at high level that was even increased compared to the acute phase. In sharp contrast, whereas SI-IEL from the IL-15 KO animals had very low functional activity, the frequency of B8R tetramer+ CD8+ T cells with high TCR expression was comparable with that found in the WT mice. Strikingly, during the memory phase SI-IEL from IL-15 KO mice revealed an inverse proportion of high-to-low TCR expression subsets, where the latter comprised up to 67% compared to 27% for the WT mice. However, due to the fact that the physical avidity of B8R tetramer+ CTL in the SI-IEL was even higher compared with the spleen (Fig.4; WT mice), we may conclude that assessment of both functional and physical avidities maybe of special importance for antigen-specific CD8 T cells residing in non-lymphoid tissues. Altogether, IL-15 turned out to participate not only in expansion of memory CD8+ T cell precursors (see Fig. 1), but also in development of their full functional activity, which was evident during the acute phase of infection (decreased number of total and high avidity responders). In particular, the lack of IL-15 in vivo mostly affected functional activity/development of middle-to-high avidity CD8+ T cells and had less impact on low avidity T cells, consistent with our earlier finding that IL-15 promotes induction of high avidity CTLs [54].
A special role for IL-7 and IL-15 for survival and homeostatic proliferation of memory CTLs has been documented in numerous studies [18–23, 25, 35, 55, 56]. As we were able to detect memory CTLs in the SI-IEL from the IL-15 KO animals we decided to check if their survival was linked to CD127 expression and IL-7 signaling. We showed by flow cytometry that during the acute phase the vast majority of B8R tetramer+ CD8+ T cells isolated from SI-IEL both in the IL-15 KO and WT mice were negative for CD127 expression (Fig.5), consistent with data published elsewhere [34]. Additionally, we found that the memory CTLs from LP were negative for CD127 as well (Fig.5), suggesting that some alternative pro-survival factor(s) specific to the epithelial layer of the small intestine might exist. Such assumption is substantiated by the finding that even in naïve C57BL/6 animals some non-specific “memory-like” TCRβ+CD8αβ+ T cells may be detected in the SI-IEL, which express CD127/IL-7Rα at very low levels [57]. Here, we proved that despite the low frequency of CD127+ SI-IEL, these few cells were capable of transducing signals from IL-7 in vitro, thus confirming the functionality of CD127/IL-7Rα on the gut CD8αβ+ T cell IEL (Fig.6). However, the vast majority of memory CD8+ T cells within intestinal epithelium was found to survive independently of CD127 expression, thus ruling out IL-7 as a necessary survival factor in this tissue. In line with this, previously it was shown that other cytokines, transducing signals via the common γc-chain/CD132, may influence SI-IEL development. In particular, the lack of signaling via IL-2, 4, 7, 9, 15 affected only TCRαβ+CD8αα+ and TCRγδ+CD8αα+ IEL subsets [58–62], seemingly having no major impact on TCRαβ+CD8αβ+ IELs. On the other hand, selective overexpression of either IL-7 [63] or IL-15 [64] by the gut epithelium did not result in increased frequency of CD8αβ+ T cells in SI-IEL, possibly because TCRαβ+ SI-IEL in naïve mice express few if any receptors for IL-2, 4, 7, 15 [65]. Similarly, splenic TCRαβ+CD8αβ+ T cells in naive mice do not entirely depend on the IL-15 signaling as they still contain CD44loCD122lo precursors of “conventional” TCRαβ+CD8αβ+ T cells that were described in IL-15 KO mice, thus, arguing for their IL-15–independent maintenance [66]. In fact, additional molecules might have had even bigger impact on their pro-survival program (e.g. itk and IRF-1 etc.; [67, 68]). Based on this, we reasoned that in contrast to the role for IL-7 and IL-15 documented in peripheral lymphoid tissues, some other cytokine/cell contact factors might be involved in long-term maintenance of memory CD8αβ+ T cells in non-lymphoid tissues (intestinal epithelium; [69]). Even though some memory intraepithelial CD8+ T cells can survive in the small intestine in IL-15 KO mice after mucosal vaccination with MVA, these mice will be significantly less protected against mucosal challenge with WR virulent vaccinia virus compared to WT mice. Some studies demonstrated already that IL-15 plays an important role in protection, especially in early activation of memory CD8+ CTL after reinfection [70].
As was shown above, not only survival but also functional activity of the gut memory CTLs was compromised in the IL-15 KO mice. It is known that the local tissue microenvironment (cytokine, chemokine, TLR-ligands, cell-cell contacts) can significantly influence the pathway of antigen presentation that elicits proliferation and differentiation of CD8 T cells, affecting cytokine profile and memory responses [71–76]. Inclusion of cytokines and other biological adjuvants into vaccine formulas can facilitate skewing immune responses both quantitatively and qualitatively in desirable directions [3, 76]. As a result of such strategy, previously we found a synergistic effect of cytokines and mucosal adjuvants for induction of mucosal and systemic CD8+ T cell responses together with protective immunity against mucosal viral challenge [12, 50]. Moreover, such protection was mediated by CD8+ T-cells and was associated with their presence at the mucosal site [77, 78]. Our studies provided a better understanding of the effects that local microenvironment (cytokines, cell contact signals) might have on generation of memory CTL, particularly at mucosal sites. An important factor for development of effective memory CD8+ T cells is the presence of tissue-specific pro-survival factors. Our current study, demonstrated that the mechanisms of CTL survival in mucosal tissues (small intestinal epithelium) may differ from those present in peripheral lymphoid tissues.
As memory CTL which reside in the gut SI-IEL are non-migrating cells [46] and can not recirculate with pool of systemic memory CTLs, they are unable to obtain pro-survival signals produced within lymphoid tissues, e.g. IL-7 and IL-15. Thus, it is important to pin-point what additional factors may contribute to their survival. Apart from different signaling molecules involved in this process, it is also plausible that the gut memory CTLs might merely depend on the abundancy of nutrient factors supplied from food, in particular, glucose. It is worth mentioning that in response to high glucose concentration some gut epithelial cell types are able to produce IL-10 [79], that may also contribute to IEL survival especially when they are deprived of growth factors [80].
Despite the fact that currently no cytokine/cell contact molecule(s) responsible for survival of TCRαβ+CD8αβ+ SI-IEL has been identified, still it is plausible to deduce that somehow they may integrate signals which elicit constitutive expression of anti-apoptotic factors including cIAP-1, XIAP, bcl-xL, and Mcl-1 as it was found in naïve animals [81]. In fact, antigen-specific memory TCRαβ+CD8αβ+ from both spleen and SI-IEL do express bcl-2 at high levels [34].
Besides classic surface markers that help to distinguish between naïve and memory CD8+ T cells [31], little is known about expression of the activating NKG2D molecule on the CD8+ T cells in the SI-IEL. As a number of its ligands are expressed by the gut epithelium, such ligation might be involved in providing pro-survival signals to the antigen-specific CTLs [82]. Previously, NKG2D expression was described only on a subset of splenic memory CD8+ T cells [83], which transduces activating signals by complexing with either DAP10, the only adaptor protein expressed on CD8+ T cells, and/or with DAP12 [83]. DAP10 under certain circumstances is considered to transduce co-stimulatory signals in CD8+ T cells, whereas DAP12 has direct stimulatory activity in NK cells. CD8+ T cells normally do not express DAP12; however, during in vitro stimulation with IL-2, at least CD8+CD44lo T cells do express DAP12 [84]. Importantly, in naïve mice neither TCRαβ+ nor TCRγδ+ SI-IEL express NKG2D, i.e. that only cytokine-specific and/or antigen-specific activation may be responsible for NKG2D expression [65, 83]. Thus, we speculated that during antigen-specific stimulation, signaling via NKG2D in CD8+ SI-IEL might substitute for the lack of pro-survival IL-7 and IL-15. We found that the frequency of NKG2D+ cells was increased in IEL (and LP) from IL-15 KO mice at memory phase compared with acute phase (Fig.8). We may suppose that at least, in part, NKG2D expression may be associated with CTL survival both in the SI-IEL and SI-LP compartments.
Additionally, we investigated expression on B8R tetramer+ CD8 T cells of CD8αα homodimer (Fig.9), which binds to the thymus leukemia (TL) antigen, known to be abundantly expressed on the basolateral membrane of mouse intestinal epithelium [45]. Due to the fact that the CD8αα homodimer was shown to be transiently expressed on activated CTLs, we thought it might contribute to the survival and differentiation of CD8 memory T cell precursors. Although interaction of CD8αα homodimer with TL may be of some importance in antigen-experienced CTL, however, it was not involved in survival of non-specific CD8αα+ TCRαβ+ and CD8αα+ TCRγδ+ IEL [85]. In our study we saw that during both acute and memory phases the frequency of CD8αα+ B8R tetramer+ CTLs was increased only in the SI-IEL from IL-15 KO but not from WT mice (Fig.9). Collectively, around 16 and 21% of total memory CTL in the SI-IEL from WT and IL-15 KO mice were positive for either NKG2D or CD8αα, which could bind to the gut epithelium-specific ligands (Fig.8 and 9). These results raise the possibility that somehow memory CTL from SI-IEL compartment were shifting their programs towards higher frequencies of NKG2D+ and CD8αα+ that might be associated with their survival in the absence of IL-7 and IL-15 signaling.
Altogether, our findings emphasize that the local tissue environment in the intestinal mucosa is unique, and shapes and organizes very specific populations of different protective lymphocytes and allows CD8+ T cell survival without IL-7 or IL-15 signaling. Furthermore, an environmental condition in the intestinal epithelium does not promote IFN-γ production by SI-IEL long after vaccination, whereas in the adjacent lamina propria they are enriched with high avidity IFN-γ producing CD8+ CTLs [53]. What factors contribute to development of pro-survival conditions that facilitate maintenance of antigen-specific T cells in the gut mucosa and their unique pattern of functional activity remains to be investigated.
4. Materials and methods
4.1. Mice
Female C57BL/6 mice were purchased from the Frederick Cancer Research Center (Frederick, MD). IL-15 KO mice on H2-Kb genetic background were purchased from Jackson Laboratories.
4.2. Viruses and immunization protocol
MVA, developed by A. Mayr, University of Munich, Germany [86], was propagated and titrated in chicken embryo fibroblast cells. This virus was a gift of Drs. Bernard Moss, Patricia Earl and Linda Wyatt (NIAID). For immunization, mice were injected IR with 107 pfu MVA as previously described [87].
4.3. Cell purification: Isolation of small intestinal intraepithelial and lamina propria lymphocytes, and lymphocytes from the spleen
Spleens were aseptically removed and single-cell suspensions were prepared by gentle passage of the tissue through sterile screens. SI-IEL and LPLs from mice were isolated as previously described with a minor modification [52].
4.4. Flow cytometry
Flow cytometry was performed by using a FACScalibur, and data were further analyzed with CellQuest software (BD Biosciences) [88]. The following mAbs were used: FITC-conjugated anti-CD62L (clone 53–5.8; obtained from BD Biosciences), APC-conjugated anti-CD127 (clone A7R34); APC-conjugated anti-NKG2D (clone CX5), APC-conjugated anti-CD8β (clone CT-CD8b; all obtained from eBiosciences). Soluble tetrameric B8R20–27/H2-Kb complex was conjugated to PE-labeled streptavidin (made by the NIH Tetramer Core Facility).
4.5. IL-7 Bioassay
Lymphocytes from naïve WT animals were either treated with recombinant murine IL-7 (rmIL-7; PeproTech Inc.) in DPBS/1%BSA or kept untreated, and incubated for 20 min at 37°C. To verify rmIL-7-specific signaling, cells were stained for intracellular phosphorylated STAT5 protein with anti-phospho STAT5 (Y694) Alexa Fluor®−488 mAbs according to the manufacturer (clone 47; BD™ PhosFlow) and studied by flow cytometry. Additionally cells were stained with mAbs against APC-conjugated anti-CD127 (clone A7R34; eBiosciences).
4.6. IFN-γ ELISpot
IFN-γ ELISpot were performed as previously described [89]. Cells were plated in triplicates in a volume of 200 μl, 0.2 × 106 /well, to which we directly added titrated amounts of B8R20–27 peptide (TSYKFESV), which is an immunodominant poxvirus CTL epitope restricted by H-2Kb [36]. Spots were counted in AID ELISpot Reader (Cell Technology, Inc.). Data are presented as the mean and SEM of three animals per interval. These experiments were performed twice with comparable results.
4.7. Statistical analysis
Statistical comparisons were assessed by unpaired Student’s t-test and Mann-Whitney test by using GraphPad Prism version 5.00, GraphPad Software (San Diego CA; www.graphpad.com).
Acknowledgments
We would like to thank Drs. Brian Kelsall and Warren Leonard for critical comments on the manuscript and helpful suggestions. We thank Drs. Bernard Moss and Linda Wyatt for providing the MVA. We thank the NIH Tetramer Core Facility for providing B8R20–27/ H-2Kb PE-labeled tetramer. This work was carried out with the support of the intramural program of the Center for Cancer Research, National Cancer Institute and NIH.
Footnotes
Conflict of Interest
Authors have no financial or commercial conficts of interests.
References
- 1.Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A and Dandekar S, Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003. 77: 11708–11717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P and Markowitz M, Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract. J Exp Med 2004. 200: 761–770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sui Y, Zhu Q, Gagnon S, Dzutsev A, Terabe M, Vaccari M, Venzon D, Klinman D, Strober W, Kelsall B, Franchini G, Belyakov IM and Berzofsky JA, Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc Natl Acad Sci U S A 2010. 107: 9843–9848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Belyakov IM and Berzofsky JA, Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 2004. 20: 247–253. [DOI] [PubMed] [Google Scholar]
- 5.Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, Rosenzweig M, Johnson RP, Desrosiers RC and Lackner AA, Gastrointestinal Tract as a Major Site of CD4+ T Cell Depletion and Viral Replication in SIV Infection. Science 1998. 280: 427–431. [DOI] [PubMed] [Google Scholar]
- 6.Berzofsky JA, Ahlers J, Janik J, Morris J, Oh S, Terabe M and Belyakov IM, Progress on new vaccine strategies against chronic viral infections. J Clin Invest 2004. 114: 450–462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Belyakov IM, Ahlers JD and Berzofsky JA, Mucosal AIDS vaccines: current status and future directions. Expert Rev. Vaccines 2004. 3: Suppl 65–73. [DOI] [PubMed] [Google Scholar]
- 8.Belyakov IM and Ahlers JD, What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens? J Immunol 2009. 183: 6883–6892. [DOI] [PubMed] [Google Scholar]
- 9.Ahlers JD and Belyakov IM, Strategies for optimizing targeting and delivery of mucosal HIV vaccines. Eur J Immunol 2009. 39: 2657–2669. [DOI] [PubMed] [Google Scholar]
- 10.Belyakov IM, Ahlers JD, Brandwein BY, Earl P, Kelsall BL, Moss B, Strober W and Berzofsky JA, The Importance of local mucosal HIV-specific CD8+ cytotoxic T lymphocytes for resistance to mucosal-viral transmission in mice and enhancement of resistance by local administration of IL-12. J.Clin.Invest. 1998. 102 (12): 2072–2081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Belyakov IM, Derby MA, Ahlers JD, Kelsall BL, Earl P, Moss B, Strober W and Berzofsky JA, Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc.Natl.Acad.Sci.U.S.A. 1998. 95: 1709–1714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Belyakov IM, Ahlers JD, Clements JD, Strober W and Berzofsky JA, Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific cytotoxic T lymphocytes. J. Immunol. 2000. 165: 6454–6462. [DOI] [PubMed] [Google Scholar]
- 13.Berzofsky JA, Ahlers JD and Belyakov IM, Strategies for designing and optimizing new generation vaccines. Nature Reviews Immunology 2001. 1: 209–219. [DOI] [PubMed] [Google Scholar]
- 14.Pal R, Venzon D, Santra S, Kalyanaraman VS, Montefiori DC, Hocker L, Hudacik L, Rose N, Nacsa J, E.-S. Y, Belyakov IM, Berzofsky JA, Washington Parks R, Markham P, Letvin NL, Tartaglia J and Franchini G, Systemic Immunization with an ALVAC-HIV-1/Protein Boost Vaccine Strategy Protects Rhesus Macaques from CD4+ T-Cell Loss and Reduces Both Systemic and Mucosal SHIVKU2 RNA Levels. Journal of Virology 2006. 80: 3732–3742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Patel V, Valentin A, Kulkarni V, Rosati M, Bergamaschi C, Jalah R, Alicea C, Minang JT, Trivett MT, Ohlen C, Zhao J, Robert-Guroff M, Khan AS, Draghia-Akli R, Felber BK and Pavlakis GN, Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization. Vaccine 2010. 28: 4827–4836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kaufman DR, Bivas-Benita M, Simmons NL, Miller D and Barouch DH, Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes. J Virol 2010. 84: 5986–5996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, Ma A and Ahmed R, Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 2002. 195: 1541–1548. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lodolce JP, Burkett PR, Boone DL, Chien M and Ma A, T cell-independent interleukin 15ralpha signals are required for bystander proliferation. J Exp Med 2001. 194: 1187–1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Prlic M, Lefrancois L and Jameson SC, Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. J Exp Med 2002. 195: F49–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Geginat J, Sallusto F and Lanzavecchia A, Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med 2001. 194: 1711–1719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Berard M, Brandt K, Bulfone-Paus S and Tough DF, IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J Immunol 2003. 170: 5018–5026. [DOI] [PubMed] [Google Scholar]
- 22.Manjunath N, Shankar P, Wan J, Weninger W, Crowley MA, Hieshima K, Springer TA, Fan X, Shen H, Lieberman J and von Andrian UH, Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest 2001. 108: 871–878. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Judge AD, Zhang X, Fujii H, Surh CD and Sprent J, Interleukin 15 Controls both Proliferation and Survival of a Subset of Memory-Phenotype CD8(+) T Cells. J Exp Med 2002. 196: 935–946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J and Surh CD, Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002. 195: 1523–1532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Sato N, Patel HJ, Waldmann TA and Tagaya Y, The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc Natl Acad Sci U S A 2007. 104: 588–593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wu Z, Xue HH, Bernard J, Zeng R, Issakov D, Bollenbacher-Reilley J, Belyakov IM, Oh S, Berzofsky JA and Leonard WJ, The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation. Blood 2008. 112: 4411–4419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Roychowdhury S, May KF Jr., Tzou KS, Lin T, Bhatt D, Freud AG, Guimond M, Ferketich AK, Liu Y and Caligiuri MA, Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2. Cancer Res 2004. 64: 8062–8067. [DOI] [PubMed] [Google Scholar]
- 28.Ahlers JD and Belyakov IM, Memories that last forever: strategies for optimizing vaccine T-cell memory. Blood 2010. 115: 1678–1689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Ahlers JD and Belyakov IM, Lessons learned from natural infection: focusing on the design of protective T cell vaccines for HIV/AIDS. Trends Immunol 2010. 31: 120–130. [DOI] [PubMed] [Google Scholar]
- 30.Ahlers JD and Belyakov IM, Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines. Trends Mol Med 2009. 15: 263–274. [DOI] [PubMed] [Google Scholar]
- 31.Wherry EJ and Ahmed R, Memory CD8 T-cell differentiation during viral infection. J Virol 2004. 78: 5535–5545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Sallusto F, Lenig D, Forster R, Lipp M and Lanzavecchia A, Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708–712. [DOI] [PubMed] [Google Scholar]
- 33.Masopust D, Vezys V, Marzo AL and Lefrancois L, Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001. 291: 2413–2417. [DOI] [PubMed] [Google Scholar]
- 34.Masopust D, Vezys V, Wherry EJ, Barber DL and Ahmed R, Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J Immunol 2006. 176: 2079–2083. [DOI] [PubMed] [Google Scholar]
- 35.Schluns KS and Lefrancois L, Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003. 3: 269–279. [DOI] [PubMed] [Google Scholar]
- 36.Tscharke DC, Karupiah G, Zhou J, Palmore T, Irvine KR, Haeryfar SM, Williams S, Sidney J, Sette A, Bennink JR and Yewdell JW, Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 2005. 201: 95–104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Crawford F, Kozono H, White J, Marrack P and Kappler J, Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 1998. 8: 675–682. [DOI] [PubMed] [Google Scholar]
- 38.Nguyen LT, Elford AR, Murakami K, Garza KM, Schoenberger SP, Odermatt B, Speiser DE and Ohashi PS, Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. J Exp Med 2002. 195: 423–435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, Mathis D and Butz EA, Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 2002. 195: 1515–1522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Laouar A, Haridas V, Vargas D, Zhinan X, Chaplin D, van Lier RA and Manjunath N, CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa. Nat Immunol 2005. 6: 698–706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Jiang W, Ferrero I, Laurenti E, Trumpp A and MacDonald HR, c-Myc controls the development of CD8alphaalpha TCRalphabeta intestinal intraepithelial lymphocytes from thymic precursors by regulating IL-15-dependent survival. Blood 2010. 115: 4431–4438. [DOI] [PubMed] [Google Scholar]
- 42.Luckschander N, Pfammatter NS, Sidler D, Jakob S, Burgener IA, Moore PF, Zurbriggen A, Corazza N and Brunner T, Phenotyping, functional characterization, and developmental changes in canine intestinal intraepithelial lymphocytes. Vet Res 2009. 40: 58. [DOI] [PubMed] [Google Scholar]
- 43.Kim S-K, Reed DS, Heath WR, Carbone F and Lefrançois L, Activation and migration of CD8 T cells in the intestinal mucosa1. J.Immunol. 1997. 159: 4295–4306. [PubMed] [Google Scholar]
- 44.Wu M, van Kaer L, Itohara S and Tonegawa S, Highly restricted expression of the thymus leukemia antigens on intestinal epithelial cells. J Exp Med 1991. 174: 213–218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Madakamutil LT, Christen U, Lena CJ, Wang-Zhu Y, Attinger A, Sundarrajan M, Ellmeier W, von Herrath MG, Jensen P, Littman DR and Cheroutre H, CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors. Science 2004. 304: 590–593. [DOI] [PubMed] [Google Scholar]
- 46.Masopust D, Choo D, Vezys V, Wherry EJ, Duraiswamy J, Akondy R, Wang J, Casey KA, Barber DL, Kawamura KS, Fraser KA, Webby RJ, Brinkmann V, Butcher EC, Newell KA and Ahmed R, Dynamic T cell migration program provides resident memory within intestinal epithelium. J Exp Med 2010. 207: 553–564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR and Carbone FR, Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 2009. 10: 524–530. [DOI] [PubMed] [Google Scholar]
- 48.Belyakov IM and Ahlers JD, Functional CD8(+) CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine. Trends Immunol 2008. 29: 574–585. [DOI] [PubMed] [Google Scholar]
- 49.Belyakov IM, Ahlers JD, Nabel GJ, Moss B and Berzofsky JA, Generation of functionally active HIV-1 specific CD8(+) CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization. Virology 2008. 381: 106–115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Belyakov IM and Ahlers JD, Mucosal Immunity and HIV-1 Infection: Applications for Mucosal AIDS Vaccine Development. Curr Top Microbiol Immunol 2011. [DOI] [PubMed] [Google Scholar]
- 51.Belyakov IM, Hel Z, Kelsall B, Kuznetsov VA, Ahlers JD, Nacsa J, Watkins D, Allen TM, Sette A, Altman J, Woodward R, Markham P, Clements JD, Franchini G, Strober W and Berzofsky JA, Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nature Medicine 2001. 7: 1320–1326. [DOI] [PubMed] [Google Scholar]
- 52.Belyakov IM, Isakov D, Zhu Q, Dzutsev A and Berzofsky JA, A Novel Functional CTL Avidity/Activity Compartmentalization to the Site of Mucosal Immunization Contributes to Protection of Macaques Against Simian/Human Immunodeficiency Viral Depletion of Mucosal CD4+ T cells. J Immunol 2007. 178: 7211–7221. [DOI] [PubMed] [Google Scholar]
- 53.Isakov D, Dzutsev A, Belyakov IM and Berzofsky JA, Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa. Mucosal Immunol 2009. 2: 450–461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Oh S, Perera LP, Burke DS, Waldmann TA and Berzofsky JA, IL-15/IL-15R alpha-mediated avidity maturation of memory CD8+ T cells. Proc Natl Acad Sci U S A 2004. 101: 15154–15159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Waldmann TA, Dubois S and Tagaya Y, Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001. 14: 105–110. [PubMed] [Google Scholar]
- 56.Burkett PR, Koka R, Chien M, Chai S, Chan F, Ma A and Boone DL, IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory. Proc Natl Acad Sci U S A 2003. 100: 4724–4729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Kunisawa J, Kurashima Y, Higuchi M, Gohda M, Ishikawa I, Ogahara I, Kim N, Shimizu M and Kiyono H, Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium. J Exp Med 2007. 204: 2335–2348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Porter BO and Malek TR, IL-2Rbeta/IL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (IEL) developmental defects of gammac−/− mice: roles for both IL-2 and IL-15 in CD8alphaalpha IEL development. J Immunol 1999. 163: 5906–5912. [PubMed] [Google Scholar]
- 59.Malek TR, Levy RB, Adkins B and He YW, Monoclonal antibodies to the common gamma-chain as cytokine receptor antagonists in vivo: effect on intrathymic and intestinal intraepithelial T lymphocyte development. J Leukoc Biol 1998. 63: 643–649. [DOI] [PubMed] [Google Scholar]
- 60.Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JCL, Joyce S and Peschon JJ, Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15- deficient mice. J Exp.Med. 2000. 191: 771–780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Kaneko M, Mizunuma T, Takimoto H and Kumazawa Y, Development of TCR alpha beta CD8 alpha alpha intestinal intraepithelial lymphocytes is promoted by interleukin-15-producing epithelial cells constitutively stimulated by gram-negative bacteria via TLR4. Biol Pharm Bull 2004. 27: 883–889. [DOI] [PubMed] [Google Scholar]
- 62.Suzuki H, Duncan GS, Takimoto H and Mak TW, Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J Exp Med 1997. 185: 499–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Laky K, Lefrancois L, Lingenheld EG, Ishikawa H, Lewis JM, Olson S, Suzuki K, Tigelaar RE and Puddington L, Enterocyte expression of interleukin 7 induces development of gammadelta T cells and Peyer’s patches. J Exp Med 2000. 191: 1569–1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Ohta N, Hiroi T, Kweon MN, Kinoshita N, Jang MH, Mashimo T, Miyazaki J and Kiyono H, IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation. J Immunol 2002. 169: 460–468. [DOI] [PubMed] [Google Scholar]
- 65.Shires J, Theodoridis E and Hayday AC, Biological insights into TCRgammadelta+ and TCRalphabeta+ intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). Immunity 2001. 15: 419–434. [DOI] [PubMed] [Google Scholar]
- 66.Dubois S, Waldmann TA and Muller JR, ITK and IL-15 support two distinct subsets of CD8+ T cells. Proc Natl Acad Sci U S A 2006. 103: 12075–12080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A and et al. , Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993. 75: 83–97. [PubMed] [Google Scholar]
- 68.Ohteki T, Yoshida H, Matsuyama T, Duncan GS, Mak TW and Ohashi PS, The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J Exp Med 1998. 187: 967–972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Huleatt JW and Lefrancois L, Beta2 integrins and ICAM-1 are involved in establishment of the intestinal mucosal T cell compartment. Immunity 1996. 5: 263–273. [DOI] [PubMed] [Google Scholar]
- 70.Yajima T, Nishimura H, Sad S, Shen H, Kuwano H and Yoshikai Y, A novel role of IL-15 in early activation of memory CD8+ CTL after reinfection. J Immunol 2005. 174: 3590–3597. [DOI] [PubMed] [Google Scholar]
- 71.Ahlers JD, Belyakov IM and Berzofsky JA, Cytokine, chemokine and costimulatory molecule modulation to enhance efficacy of HIV vaccines. Current Molecular Medicine 2003. 3: 285–301. [DOI] [PubMed] [Google Scholar]
- 72.Ahlers JD, Belyakov IM, Thomas EK and Berzofsky JA, High affinity T-helper epitope induces complementary helper and APC polarization, increased CTL and protection against viral infection. J. Clin. Invest. 2001. 108: 1677–1685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Ahlers JD, Belyakov IM, Matsui S and Berzofsky JA, Mechanisms of cytokine synergy essential for vaccine protection against viral challenge. Int Immunol 2001. 13: 897–908. [DOI] [PubMed] [Google Scholar]
- 74.Hodge JW, Grosenbach DW, Rad AN, Giuliano M, Sabzevari H and Schlom J, Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules. Vaccine 2001. 19: 3552–3567. [DOI] [PubMed] [Google Scholar]
- 75.Zhu Q, Egelston C, Vivekanandhan A, Uematsu S, Akira S, Klinman DM, Belyakov IM and Berzofsky JA, Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc Natl Acad Sci U S A 2008. 105: 16260–16265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Zhu Q, Egelston C, Gagnon S, Sui Y, Belyakov IM, Klinman DM and Berzofsky JA, Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest 2010. 120: 607–616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Staats HF, Bradney CP, Gwinn WM, Jackson SS, Sempowski GD, Liao HX, Letvin NL and Haynes BF, Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization. J Immunol 2001. 167: 5386–5394. [DOI] [PubMed] [Google Scholar]
- 78.Ahlers JD, Belyakov IM, Terabe M, Koka R, Donaldson DD, Thomas E and Berzofsky JA, A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with GM-CSF and CD40L. Proc Natl Acad Sci U S A 2002. 99: 13020–13025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Palazzo M, Gariboldi S, Zanobbio L, Selleri S, Dusio GF, Mauro V, Rossini A, Balsari A and Rumio C, Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa. J Immunol 2008. 181: 3126–3136. [DOI] [PubMed] [Google Scholar]
- 80.Ina K, Kusugami K, Kawano Y, Nishiwaki T, Wen Z, Musso A, West GA, Ohta M, Goto H and Fiocchi C, Intestinal fibroblast-derived IL-10 increases survival of mucosal T cells by inhibiting growth factor deprivation- and Fas-mediated apoptosis. J Immunol 2005. 175: 2000–2009. [DOI] [PubMed] [Google Scholar]
- 81.Brunner T, Arnold D, Wasem C, Herren S and Frutschi C, Regulation of cell death and survival in intestinal intraepithelial lymphocytes. Cell Death Differ 2001. 8: 706–714. [DOI] [PubMed] [Google Scholar]
- 82.Eagle RA and Trowsdale J, Promiscuity and the single receptor: NKG2D. Nat Rev Immunol 2007. 7: 737–744. [DOI] [PubMed] [Google Scholar]
- 83.Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR and Raulet DH, The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002. 17: 19–29. [DOI] [PubMed] [Google Scholar]
- 84.Dhanji S and Teh HS, IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells. J Immunol 2003. 171: 3442–3450. [DOI] [PubMed] [Google Scholar]
- 85.Pardigon N, Darche S, Kelsall B, Bennink JR and Yewdell JW, The TL MHC class Ib molecule has only marginal effects on the activation, survival and trafficking of mouse small intestinal intraepithelial lymphocytes. Int Immunol 2004. 16: 1305–1313. [DOI] [PubMed] [Google Scholar]
- 86.Mayr A, Hochstein-Mintzel V and Stickl H, Abstammung, eigenschaften and verwendung des attenuierten vaccinia-stammes MVA. Infection 1975. 3: 6–14. [Google Scholar]
- 87.Belyakov IM, Wyatt LS, Ahlers JD, Earl P, Pendleton CD, Kelsall BL, Strober W, Moss B and Berzofsky JA, Induction of mucosal CTL response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing HIV 89.6 envelope protein. J.Virol. 1998. 72: 8264–8272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Dzutsev AH, Belyakov IM, Isakov DV, Margulies DH and Berzofsky JA, Avidity of CD8 T cells sharpens immunodominance. Int Immunol 2007. 19: 497–507. [DOI] [PubMed] [Google Scholar]
- 89.Belyakov IM, Isakov D, Zhu Q, Dzutsev A, Klinman D and Berzofsky JA, Enhancement of CD8+ T cell immunity in the lung by CpG ODN increases protective efficacy of a Modified Vaccinia Ankara vaccine against lethal poxvirus infection even in CD4-deficient host. J Immunol 2006. 177: 6336–6343. [DOI] [PubMed] [Google Scholar]
